Wednesday, October 23, 2024 11:04:14 AM
The run up to 0.97 in 2014 was all about only 1 thing, SequestOx. Elite is no longer a one horse wonder.
- We have growing revenues and profits that will continue to break records quarter after quarter. Next record breaking announcement will be in 3 weeks.
- We have a billion dollars in opioid products that will be launched in the next 3 months.
- We have a product with multiple billion dollar market value under review now and expected to be approved in the next few weeks.
- We have studies ongoing for at least 2 billion plus dollar products that could get successful BE approvals in the next 2 and a half months.
These are definitely different times for Elite.
Our run straight up wasn't natural. We all knew it, but enjoyed the ride anyway. Now we are backfilling the prices that were skipped. The company is not diluting every share bought is coming from someone that sold, not created out of thin air. All these purchases in the mid-to upper 40s are going to be sticking around as I do not see us collapsing and in the upper 30 to low 40 cent range. We traded millions of shares in that range from mid-Sept through mid-Oct (meaning only a week ago!).
- We have growing revenues and profits that will continue to break records quarter after quarter. Next record breaking announcement will be in 3 weeks.
- We have a billion dollars in opioid products that will be launched in the next 3 months.
- We have a product with multiple billion dollar market value under review now and expected to be approved in the next few weeks.
- We have studies ongoing for at least 2 billion plus dollar products that could get successful BE approvals in the next 2 and a half months.
These are definitely different times for Elite.
Our run straight up wasn't natural. We all knew it, but enjoyed the ride anyway. Now we are backfilling the prices that were skipped. The company is not diluting every share bought is coming from someone that sold, not created out of thin air. All these purchases in the mid-to upper 40s are going to be sticking around as I do not see us collapsing and in the upper 30 to low 40 cent range. We traded millions of shares in that range from mid-Sept through mid-Oct (meaning only a week ago!).
Recent ELTP News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2026 12:05:23 PM
- Elite Pharmaceuticals Announces Commercial Launch of Methadone Hydrochloride Tablets • Newsfile • 04/02/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/17/2026 10:10:32 PM
- Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2026 (three months ended December 31, 2025) and Provides Conference Call Information • Newsfile • 02/17/2026 09:19:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/17/2026 09:06:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/11/2026 09:35:26 PM
- Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2026 Financial Results on February 18, 2026 • Newsfile • 02/11/2026 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2026 09:35:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2025 10:10:23 PM
- Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2026 Ended September 30, 2025 and Provides Conference Call Information • Newsfile • 11/14/2025 09:19:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:11:38 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 11/12/2025 10:19:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2025 12:15:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/10/2025 12:15:46 PM
- Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2026 Financial Results on November 17, 2025 • Newsfile • 11/10/2025 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/26/2025 09:17:39 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/22/2025 01:39:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2025 08:37:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2025 08:35:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/25/2025 10:05:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/10/2025 08:17:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/08/2025 08:15:11 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/08/2025 02:58:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/30/2025 08:27:51 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 06/30/2025 08:05:59 PM
